Regulators are reviewing what could become a multi-billion-dollar drug.
Bajaj Holdings & Investment Ltd. key Products/Revenue Segments include Dividend, Income From Sale Of Share & Securities, Interest and Rental Income for the year ending 31-Mar-2024.For the quarter ...